Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Ambu A/S

Healthcare US AMBBY

9.51USD
0.00(0%)

Last update at 2026-06-23T20:00:00Z

Day Range

9.519.51
LowHigh

52 Week Range

10.0017.69
LowHigh

Fundamentals

  • Previous Close 9.51
  • Market Cap2962.65M
  • Volume100
  • P/E Ratio34.38
  • Dividend Yield3.89%
  • EBITDA858.00M
  • Revenue TTM6085.00M
  • Revenue Per Share TTM22.86
  • Gross Profit TTM 3655.00M
  • Diluted EPS TTM0.32

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax 711.13M 300.00M 210.00M 109.00M 308.00M
Minority interest - - - - -
Net income 573.61M 235.00M 168.00M 93.00M 247.00M
Selling general administrative - 660.00M 594.00M 517.00M 470.00M
Selling and marketing expenses - 1571.00M 1522.00M 1634.00M 1468.00M
Gross profit 3183.00M 3201.00M 2713.00M 2554.00M 2503.00M
Reconciled depreciation - 696.00M 348.00M 351.00M 216.00M
Ebit 739.62M 327.00M 280.00M 144.00M 340.00M
Ebitda 1090.00M 682.00M 628.00M 495.00M 563.00M
Depreciation and amortization 350.38M 355.00M 348.00M 351.00M 223.00M
Non operating income net other - - - - -
Operating income 738.45M 645.00M 302.00M 144.00M 340.00M
Other operating expenses 4948.00M 4746.00M 4473.00M 4322.00M 3673.00M
Interest expense 28.26M 27.00M 61.00M 32.00M 26.00M
Tax provision - 65.00M 42.00M 16.00M 61.00M
Interest income - 16.00M 1.00M 1.00M 3.00M
Net interest income - -11.00000M -60.00000M -31.00000M -23.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 137.52M 65.00M 42.00M 16.00M 61.00M
Total revenue 5686.00M 5391.00M 4775.00M 4444.00M 4013.00M
Total operating expenses 2444.00M 2556.00M 2411.00M 2432.00M 2163.00M
Cost of revenue 2504.00M 2190.00M 2062.00M 1890.00M 1510.00M
Total other income expense net -27.31617M -345.00000M -92.00000M -35.00000M -32.00000M
Discontinued operations - - - - -
Net income from continuing ops - 235.00M 168.00M 93.00M 247.00M
Net income applicable to common shares - - - 93.00M 247.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 7690.00M 7154.00M 6859.00M 7215.00M 5740.00M
Intangible assets 1755.00M 1703.00M 2046.00M 1942.00M 1740.00M
Earning assets - - - - -
Other current assets 111.48M 155.00M - 895.00M 796.00M
Total liab 1643.00M 1560.00M 1466.00M 2954.00M 1788.00M
Total stockholder equity 6047.00M 5594.00M 5393.00M 4261.00M 3952.00M
Deferred long term liab - - - - -
Other current liab 507.70M 445.00M 511.00M 482.00M 137.00M
Common stock 135.27M 135.00M 135.00M 129.00M 129.00M
Capital stock - 135.00M 135.00M 129.00M 129.00M
Retained earnings 5876.00M 5212.00M 5047.00M 3753.00M 3642.00M
Other liab - - - 27.00M 48.00M
Good will 1500.00M 1527.00M 1565.00M 1623.00M 1504.00M
Other assets - - - 70.00M 42.00M
Cash 867.72M 615.00M 157.00M 187.00M 64.00M
Cash and equivalents - - - - -
Total current liabilities 1161.00M 1059.00M 942.00M 1161.00M 980.00M
Current deferred revenue - - - - 416.00M
Net debt -319.63300M -57.00000M 427.00M 1658.00M 759.00M
Short term debt 80.16M 75.00M 72.00M 79.00M 63.00M
Short long term debt - - - - -
Short long term debt total 548.09M 558.00M 584.00M 1845.00M 823.00M
Other stockholder equity - 247.00M 211.00M 379.00M 181.00M
Property plant equipment - - - 1276.00M 846.00M
Total current assets 3163.00M 2637.00M 2008.00M 2304.00M 1608.00M
Long term investments - - - - -
Net tangible assets - - - 696.00M 708.00M
Short term investments - - - - -
Net receivables 908.80M 789.00M 766.00M 806.00M 732.00M
Long term debt - - 0.00000M 1250.00M 550.00M
Inventory 1275.00M 1078.00M 907.00M 1222.00M 748.00M
Accounts payable 573.14M 490.00M 359.00M 600.00M 364.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 36.07M 145.00M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.73M - - - -
Deferred long term asset charges - - - - -
Non current assets total 4527.00M 4517.00M 4851.00M 4911.00M 4132.00M
Capital lease obligations - 558.00M 584.00M 595.00M 273.00M
Long term debt total - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - -289.00000M -326.00000M -558.00000M -874.00000M
Change to liabilities - - - 287.00M 188.00M
Total cashflows from investing activities -362.00000M -289.00000M - -558.00000M -874.00000M
Net borrowings - 0.00000M - 648.00M -743.00000M
Total cash from financing activities -144.00000M -65.00000M -222.00000M 586.00M 512.00M
Change to operating activities - - - -134.00000M -134.00000M
Net income 573.61M 235.00M 168.00M -26.00000M 340.00M
Change in cash 281.64M 458.00M -30.00000M 123.00M -34.00000M
Begin period cash flow 586.08M 157.00M 187.00M 64.00M 98.00M
End period cash flow 867.72M 615.00M 157.00M 187.00M 64.00M
Total cash from operating activities 745.04M 813.00M 518.00M 95.00M 328.00M
Issuance of capital stock - 0.00000M 1091.00M 12.00M 1327.00M
Depreciation 350.38M 696.00M 348.00M 351.00M 216.00M
Other cashflows from investing activities - -88.00000M - - 8.00M
Dividends paid 95.00M - - -75.00000M -73.00000M
Change to inventory -237.00000M -170.00000M 237.00M -402.00000M -222.00000M
Change to account receivables -101.00000M -40.00000M - -19.00000M -163.00000M
Sale purchase of stock - - - - 531.00M
Other cashflows from financing activities -59.36100M -65.00000M 262.00M 774.00M 1.00M
Change to netincome - - - -155.00000M 66.00M
Capital expenditures 110.00M 289.00M 326.00M 558.00M 584.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -266.00000M -114.00000M -21.00000M -134.00000M -197.00000M
Stock based compensation - 26.00M 17.00M 12.00M 11.00M
Other non cash items 87.04M -30.00000M 84.00M -108.00000M -42.00000M
Free cash flow 634.84M 524.00M 192.00M -463.00000M -256.00000M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AMBBY
Ambu A/S		 - -% 9.51 34.38 29.24 0.49 3.07 3.06 17.10
ABT
Abbott Laboratories		 0.90 0.99% 91.43 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 6.21 2.00% 316.21 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.055 0.07% 80.58 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.29 0.64% 45.31 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Ambu A/S

Baltorpbakken 13, Ballerup, Denmark, 2750

Key Executives

Name Title Year Born
Ms. Britt Meelby Jensen Chief Exec. Officer 1973
Mr. Thomas Frederik Schmidt Exec. VP & CFO 1971
Mr. Thomas Lykke Henriksen Head of HR Systems 1973
Mr. Henrik Ankjær Exec. VP of Global Operations NA
Mr. Nicolai Thomsen Director of Investor Relations & Strategic Financial Planning NA
Mikkel Trier Wagner Director of Corp. Communications NA
Mr. Bassel Rifai Exec. VP, Chief Marketing Officer & Pres APAC NA
Mr. Anders F. Williamsson Managing Director 1954
Mr. Måns Barsne Exec. VP of Global Innovation & Chief Innovation Officer NA
Mr. Steven R. Block CEO & Pres of USA 1963

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.